We observed that at four weeks following administration of the mRNA-based COVID-19 vaccines, the production of IFN-γ was significantly higher than before vaccination, suggesting the effectiveness of mRNA-based COVID-19 vaccines in wakening the adaptive immune response against SARS-CoV-2. The gene discussed is IFNG; the disease is COVID-19.